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Background: Women with a history of previous caesarean delivery, presenting 
with a placenta previa have become the largest group with the highest risk for 
placenta previa accreta. 
Objective: To evaluate the accuracy of ultrasound imaging in the prenatal 
diagnosis of placenta accreta and the impact of the depth of villous invasion on 
management in women presenting with placenta previa or low-lying placenta and 
with one or more prior caesarean deliveries.  
Study design:  Data sources: We searched PubMed, Google Scholar, 
clinicalTrials.gov and MEDLINE for studies published between 1982 and November 
2016. Study eligibility criteria: Cohort studies which provided data on previous 
mode of delivery, placenta previa or low-lying placenta on prenatal ultrasound 
imaging and pregnancy outcome. The initial search identified 171 records of which 
five retrospective and nine prospective cohort studies were eligible for inclusion in 
the quantitative analysis. Study appraisal and synthesis methods: The studies 
were scored on methodological quality using the Quality Assessment of Diagnostic 
Accuracy Studies tool. 
Results: The 14 cohort studies included 3889907 pregnancies presenting with 
placenta previa or low-lying placenta and one or more prior caesarean deliveries 
screened for placenta accreta. There were 328 (8.4%) cases of placenta previa 
accreta out of which 298 (90.9%) were diagnosed prenatally by ultrasound. The 
incidence of placenta previa accreta was 4.1% in women with one prior caesarean 



































































performance of ultrasound for the antenatal detection of placenta previa accreta was 
higher in prospective than retrospective studies with diagnostic odds ratios of 228.5 
(95% confidence interval [CI], 67.2–776.9) and 80.8 (95% [CI], 13.0–501.4), 
respectively. Only two studies provided detailed data on the relationship between the 
depth of villous invasion and the number of previous caesarean deliveries. 
Independently of the depth of villous invasion., Aa caesarean hysterectomy was 
performed in 208 out of 232 (89.7%) cases for which detailed data on management 
were available. Positive correlations were found in the largest prospective studies 
between the cumulative rates of the more invasive forms of accreta placentation and 
the sensitivity and specificity of ultrasound imaging but not with diagnostic odds ratio 
(DOR) values. We found no data on the ultrasound screening of placenta accreta at 
the routine mid-trimester ultrasound examination  from non-expert ultrasound units 
by non-expert operators. 
Conclusions: Planning individual management for delivery is only possible with 
accurate evaluation of prenatal risk of placenta previa accreta placentation in women 
presenting with a low-lying placenta/ previa and a history of prior caesarean delivery. 
Ultrasound is highly sensitive and specific in the prenatal diagnosis of accreta 
placentation when performed by skilled operators in women presenting with placenta 
previa and a history of prior caesarean delivery. Developing a prenatal screening 
protocol is now essential to further improve the outcome of this increasingly more 
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Placenta accreta is a complication of human placentation first defined in 1937 by 
Irving and Hertig, as the “abnormal adherence of the afterbirth in whole or in parts to 
the underlying uterine wall”.1 Histopathologically, placenta accreta is now universally 
defined by a partial or complete absence of decidua basalis, resulting in placental 
villi being attached to or invading into the scarred myometrium underneath.2-4 
Pplacenta accreta is graded according to the depth of villous invasiveness into 
placenta creta or vera when the villi adhere to the myometrium without invading it, 
placenta increta when the villi invade the myometrium and placenta percreta when 
the villi invade down to or penetrate through the uterine serosa.2-4  
 Abnormal adherence or invasion results in the failure of the placenta to 
separate normally from the uterine wall at delivery. When unsuspected at the time of 
delivery, attempts to manually remove a placenta accreta typically provoke massive 
haemorrhage leading to high maternal morbidity and mortality. There is increasing 
evidence that multidisciplinary management of patients with suspected placenta 
accreta is superior to standard obstetric care.5-7 For such care to be organized, the 
diagnosis must be made prenatally.8-10 Recent population studies have shown that 
accreta placentation remains undiagnosed before delivery in half11,12 to two-third of 
the cases.13 Even in series from specialist centres around up to a third of cases of 
placenta accreta are not diagnosed during pregnancy.14 
 The incidence of placenta accreta is directly linked with the increase in 
caesarean delivery.13-19 The main additional factor for the risk of placenta accreta 
after a previous caesarean delivery is placenta praevia. The risks of both placenta 



































































of previous caesarean deliveries13,16,20,21 and is higher in women with a previous 
classical caesarean delivery.21 A large multicenter cohort study has noted that for 
women presenting with placenta praevia and prior caesarean delivery the risk of 
accreta placentation is 3%, 11%, 40%, 61%, and 67% for first, second, third, fourth, 
and fifth or more cesarean deliveries, respectively.17 These risks are independent of 
other maternal characteristics, such as parity, body mass index, tobacco use, and 
coexisting hypertension or diabetes. 2,4,14,15,17  
 Given these data, the identification at the mid-trimester ultrasound 
examination of an anterior placenta praevia or low-lying placenta in a woman with a 
history of caesarean delivery should prompt a more detailed search for signs of 
placenta accreta and evaluation of the depth of villous myometrial invasion. The 
main objective of this review is to evaluate the accuracy ultrasound imaging in 
diagnosing placenta previa accreta in women presenting prenatally with prior 
caesarean delivery. Cases of placenta accreta following other types of uterine 
surgeries were excluded from our review and analysis. We will have also evaluated 
the impact of the prenatal diagnosis of placenta praevia accreta on pregnancy 
management and outcome and address the issues in screening for these high-risk 
cases in the growing number of women with a history of caesarean delivery in the 
general population. 
 
Material and Methods 
 
Systematic review information sources and search strategy  
We undertook a PubMed, Google Scholar, clinicalTrials.gov and MEDLINE search 
for studies published between the first prenatal ultrasound description of placenta 



































































was designed a priori and registered on PROSPERO (#42016049990) 
(http://www.crd.york.ac.uk/PROSPERO). The search strategy consisted of MeSH 
headings for placenta accreta, placenta increta, placenta percreta, abnormally 
invasive placenta, morbidly adherent placenta which were combined with terms 
regarding placenta previa, low-lying placenta, sonography, ultrasound diagnosis, 
ultrasound screening, prenatal diagnosis, caesarean section, or caesarean delivery. 
Title, abstracts and full-text were independently assessed by the authors for content, 
data extraction and analysis. References of included studies were also reviewed. 
The search was limited to articles published in English. We contacted the authors for 
clarification where 2 x 2 tables could not be constructed from the published data.  
Systematic review eligibility criteria 
The primary eligibility criteria were articles which correlated prenatal ultrasound 
imaging with pregnancy outcome in women with a history of previous caesarean 
delivery and presenting with a placenta previa or low-lying placenta. We included 
retrospective and prospective cohort studies. The index test consisted of at least one 
ultrasound evaluation performed during pregnancy with the specific aim of 
diagnosing placenta accreta. The reference standard for confirmation of accreta 
placentation after delivery was histopathologic observation of placental villi directly 
attached to the myometrium or invading the uterine wall, or at delivery by direct 
observation by the operating surgeon.  
Systematic review study selection  
The initial database search provided 166 reports and cross-referencing provided an 
additional five reports, making a total of 171 records after removal of three duplicates 
(Fig. 1). Out of the 171 records screened, 86 did not include data on prenatal 



































































selection, case reports and letters with no description of the case were excluded. 
The full-text of 26 articles identified on second selection were read independently 
and examined in detail the authors. A further 12 reports where antenatal ultrasound 
was performed but the cohort studies did not include data on previous uterine 
surgery were excluded leaving 14 reports for the quantitative analysis.  
The authors independently assessed inclusion criteria, data extraction and 
analysis. The studies were scored on methodological quality using the Quality 
Assessment of Diagnostic Accuracy Studies tool (QUADAS-2) using four key 
domains: ‘patient selection’, ‘index test’, ‘reference standard’ and flow and timing’.23 
The quality items assessed were study design and the conduct and analysis of all 
included studies. Each item was scored ‘high’ or ‘low’, or ‘unclear’ if there was 
insufficient information to make an accurate judgment on the risk for bias. When 
there was inconsistency in study selection or quality assessment, we solved it by 
weighing arguments. 
We constructed two-by-two tables, cross-classifying the outcome of the index 
test against the outcome of the reference standard. Authors were contacted for 
additional data if it was not possible to create two-by-two tables. Heterogeneity was 
identified using Cochran’s Q test and the I2 statistic, in which P<0.05 and I2 ≥50% 
indicate significant heterogeneity as previously described.24 According to the results 
of heterogeneity testing, we chose a random statistical model to pool data with 95% 
confidence interval (CI) on sensitivity, specificity, positive and negative likelihood 
ratios (LR+ and LR–) and the diagnostic odds ratio (DOR) defined as the ratio of the 
odds of the test being positive if the subject has a disease relative to the odds of the 
test being positive if the subject does not have the disease. Data analysis was 



































































(http://www.hrc.es/investigacion/metadisc_en.htm) and visualized using a Forest 
plot.  
Clinical study characteristics were subsequently extracted using a 
predesigned data extraction form including: year of publication, number of cases of 
placenta praevia screened, number of placenta accreta in the study population, 
gestational age at diagnosis and histopathological confirmation (primary outcome). In 
addition, data on outcome were extracted including gestational age at delivery, type 
of management and depth of villous invasiveness (secondary outcome).  
StatGraphic data analysis and statistical software package (Manugistics, 
Rockville, MD) was used to calculate relationships between parameters when 
required. A P value of <.05 was considered significant.  
 
RESULTS 
Systematic review report characteristics 
The final selection included five retrospective25-29 and nine prospective30-38 cohort 
studies. The summarized QUADAS-2 assessment is shown in figure 2. Reference 
standard was scored unclear risk of bias in every study due to:  
1. Histopathology was not available in women not suspected of normal 
placentation who were correctly diagnosed by ultrasound.  
2. It was not generally possible to blind the pathologist to the ultimate diagnosis, 
since hysterectomy is not commonly performed in pregnancy, and invasive 
placentation is a recognised indication for Caesarean hysterectomy.  
Systematic review synthesis of results 
Table 1 displays the primary outcome characteristics of the 14 studies. These cohort 



































































lying placenta screen for placenta accreta. The largest cohort studies were US-
based.25,27,29,30-33 In total, there were 328 (8.4%) pregnancies complicated by 
placenta accreta. The incidence of placenta accreta was 14.9% (range: 7.5-29.4%) 
and 6.4% (range: 0.7-47.2%) in the retrospective and prospective cohort studies, 
respectively. Five studies included both low-lying and placenta previa in their 
screening population of women with a previous caesarean delivery.25,26,29,32,38 In only 
one of these studies29, the low-lying placenta was described as a placental edge 
within 2 cm of the cervical os but not covering it. The incidence of placenta accreta 
was lowest (0.7-8.9%) in those studies where the authors did separate low-lying 
placental position from placenta previa.25,26,32,37  
The distribution of the number of previous caesarean deliveries in women 
presenting with a placenta previa accreta confirmed at delivery was reported by eight 
authors.27-29,31,33,36-38 When pooled these data showed that out of 214 placenta 
previa accreta cases included in these studies, 50 (23.4%) women had a history of 
one previous caesarean delivery and 164 (76.6%) had >2 previous caesarean 
deliveries. When referred to the total number of women screened in those studies 
(n=1233), the incidence of placenta previa accreta was 4.1% in women with one 
previous caesarean delivery and 13.3% in women with >2 previous caesarean 
deliveries. 
Overall, 298 (90.9%) cases of placenta accreta were diagnosed prenatally by 
ultrasound and confirmed clinically at delivery and/or by histopathology. The pooled 
performance of ultrasound for the prenatal diagnosis of placenta previa accreta in 
the retrospective studies was as follows: sensitivity, 88.0% (95% confidence interval 
[CI], 81.0–93.0); specificity, 90.0% (95% CI, 88.0–93.0) and DOR, 80.8 (95% CI, 



































































respectively. In the prospective studies, the pooled performance was higher with a 
sensitivity of 97.0% (95% CI, 93.0–99.0); specificity of 97.0% (95% CI, 97.0–98.0) 
and DOR of 228.5 (95% CI, 67.2–776.9). (Fig.4). Positive and negative likelihood 
ratios were 32 and 0.03 respectively. All authors, except two30,32 used colour-Doppler 
imaging to diagnosed accreta placentation and five authors25,27,34,36,37 used MRI to 
confirmas an aid to the ultrasound diagnosis. Transvaginal ultrasound was reported 
to be used by six authors25,29,30,32,37,38 and one author reported on the use of trans-
labial ultrasound.36 
 Table 2 presents the secondary outcome characteristics of the 14 studies. 
Overall there was one maternal death and no neonatal mortality. In tFor the ten 
studies, for which detailed data on the management of placenta previa accreta at 
delivery were available, 208 out of 232 (89.7%) cases had an elective or emergent 
caesarean hysterectomy. Conservative management was attempted in seven cases, 
including in four cases a focal myometrial resection of the accreta area. Five of these 
cases failed to control the bleeding and the total number of secondary hysterectomy 
i.e. (performed as a second procedure after the baby was delivered)delivery  was 22.  
Only one small retrospective study has reported data on the depth of accreta 
placentation.26 Five retrospective studies and one prospective study (without 
outcome data)36 were not included in the secondary analysis. The pooling of data of 
the remaining studies included 84 placenta accreta vera, 53 placenta increta and 37 
placenta percreta. Two studies31,38 provided detailed data on the relationship 
between the depth of villous invasion and the number of previous caesarean 
deliveries with the following distribution: five placenta acreta, one placenta increta 
and two placenta percreta after one caesarean delivery; seven placenta  acreta, 



































































six placenta acreta, three placenta increta and eight placenta percreta after more 
than two caesarean deliveries.  Positive correlations were found in the largest 
prospective studies30-32,34,35,37,38 between the cumulative rates of the more invasive 
forms of accreta placentation and the sensitivity (F= 0.91; R= 15.4; P=0.39) and 
specificity (F= 1.35; R= 21.3; P= 0.29) of ultrasound imaging but not with DOR 
values (F= 0.34; R= 6.4; P=0.58).  
We found no data on the role of ultrasound in the screening of placenta 
accreta at the routine mid-trimester ultrasound examination by non-expert operators. 
 
COMMENT  
Principal findings of the study 
This is the first systematic review were the inclusion criteria are restricted to women 
presenting in the second trimester with a low anterior placenta/placenta previa and a 
prior caesarean delivery and the first to evaluate the relationship between the depth 
of placental invasion, outcome and management. Our results show that the accuracy 
of both grey-scale and colour-Doppler ultrasound imaging in diagnosing placenta 
previa accreta in the second trimester in women presenting with a low placenta or 
placenta previa with one or more previous caesarean delivery is high when 
performed by expert operators. Data on the relationship between the depth of villous 
invasion are limited and caesarean hysterectomy is the preferred most common 
management approach for placenta previa accreta when diagnosed prenatally. 
Conservative management failed to prevent a secondary hysterectomy in the 
majority of attempted cases.  



































































Overall, we found a 3.2-fold increase in the risk of placenta accreta after more than 
one caesarean deliveries in women presenting with placenta previa confirming the 
data of previous epidemiological studies.11,16,39,40 With the continuing increase in the 
number of caesarean section it is likely that the prevalence of placenta accreta will 
increase in the general population. Women with a previous history of caesarean 
delivery, presenting with a low-placenta or placenta previa in the second trimester of 
pregnancy have become the largest group of women at the highest risk of placenta 
accreta.  
We found a pooled sensitivity of 88% (95% CI, 81–93) and 97% (95% CI, 93-
99) in retrospective and prospective studies, respectively. Ultrasound imaging 
techniques used for the prenatal diagnosis of placenta accreta have included grey-
scale imaging, colour-Doppler imaging and three-dimensional ultrasound. Ultrasound 
machines equipped with colour-Doppler imaging and three-dimensional ultrasound 
are less widely available than grey-scale imaging machines and require more skills 
and experience. The results of well conducted prospected cohort studies by Finberg 
et al30 and Comstock et al32 have indicated that the sensitivity and specificity of grey-
scale imaging alone in diagnosing for placenta previa accreta are high when 
performed by experience operators. Finberg et al30 reported a sensitivity for grey-
scale imaging alone of 93% (95%CI, 68-100) and Comstock et reported an overall 
sensitivity of grey-scale ultrasound diagnostic criteria of 86%.  This which is contrast 
with the data from recent population studies reporting prenatal detection rates for 
placenta accreta as low as 29% including in women with prior caesarean delivery 
and diagnosed prenatally with placenta previa.13 These data suggest that colour-
Doppler imaging and three-dimensional ultrasound are not essential to the screening 



































































In the prospective cohort studies included in the present review, the pooled 
accuracy of ultrasound imaging was higher in women presenting with a placenta 
previa or low-lying placenta than those reported in a previous general systematic 
review on the prenatal diagnosis of placenta accreta by ultrasound.2441 The present 
systematic review is different as we only included women with placenta previa and 
one or more prior caesarean deliveries. In all the subsequent cohort study on the 
prenatal diagnosis of placenta accreta, except one38, the authors also included 
women with a previous history of other uterine surgery, mainly myomectomy, 
curettage and manual delivery of the placenta. Inclusion of women with previous 
uterine surgery other than a caesarean section is likely to weaken the accuracy of 
prenatal ultrasound diagnosis in women at risk of placenta accreta as the damage 
scar area can be anywhere in the uterine cavity and likely to be smaller and more 
superficial than that of a caesarean section scar.  
Clinical implications 
Accurate prenatal diagnosis is essential for women with placenta previa accreta, as 
access to the fetus during caesarean delivery is often an issue due to the anterior 
placental position. In cases of false negative prenatal diagnosis, and accreta 
placentation may not be detected by the surgeon during delivery and a routine low 
transverse uterine incision will lead to major placental blood loss, even before the 
fetus is delivered. By contrast, a false positive diagnosis of accreta placentation will 
lead to an unnecessary midline vertical skin incision and a fundal uterine incision 
increasing the risks of intra-operative and post-operative complications and the risks 
of placenta accreta and uterine rupture in subsequent pregnancies.  



































































team requires accurate prenatal diagnosis of placenta previa accreta.5-10 Prenatal 
evaluation of the depth of placental invasion can also be useful for planning of 
individual management of women diagnosed with accreta placentation.412 In 
particular, determining the degree of accreta invasion before delivery is essential to 
consent procedure, deciding on the optimal gestational age for delivery and planning 
the corresponding multidisciplinary team expertise for delivery. In a recent 
systematic review, we found that no single ultrasound sign or a combination of 
ultrasound signs were specific of the depth of accreta placentation, but that some 
signs like placental lacunae and bulge and a focal placental exophytic mass were 
more often associated with deeper invasion of the myometrium.423 In the present 
review, eight out of the nine prospective studies provided detailed information on the 
depth of invasion and ultrasound findings but not on the relationship between the 
grade of accreta placentation and outcome. In the cases included in seven 
prospective cohorts, we found positive correlations between the cumulative rates of 
the more invasive forms of accreta placentation and sensitivity (P=.39) and 
specificity (P=.29) of ultrasound imaging. There is a need for more prospective data 
on the accuracy of ultrasound imaging in determining the depth of villous invasion in 
women diagnosed with placenta previa accreta and its impact on clinical outcome. 
There are no randomized control trials comparing different surgical and non-
surgical approaches for placenta previa accreta suspected or diagnosed antenatally. 
Both conservative and radical surgical approaches can be associated with a high 
maternal morbidity, although the value of an experienced team in a centre of 
excellence decreases the risk significantly.6,7 Thurn et al have recently indicated that 
hysterectomies were performed more often in the management of placenta accreta 



































































present review support these findings withindicate that almost 90% of women 
diagnosed prenatally with placenta previa accreta haveing an elective or emergent 
caesarean hysterectomy. Emergency peripartum hysterectomy is associated with 
considerable morbidity and mortality and the risks are directly related to a previous 
caesarean delivery.434 Recent data from the Perspective database on the risks of 
peripartum hysterectomy based on placenta previa and prior caesarean delivery 
delivered in the U.S. between 2006 and 2014 have indicated that high-risk cases are 
being increasingly referred to a tertiary care hospital.445 These data also highlight the 
potential benefits of prenatal screening and diagnosis of placenta previa accreta on 
clinical outcome. 
The data of the present review underscore the pivotal role of prenatal 
ultrasound diagnosis in optimizing the counseling, management, and outcome of 
individual women with placenta previa accreta. Ultrasound screening and diagnosis 
of placenta accreta is not routinely taught during ultrasound training courses in the 
U.K.456 Introducing such a screening program has been discussed but never 
implemented.467 However, such ultrasound training and screening programs have 
existed for more than two decades for the detections of fetal anomalies such as 
congenital heart defect.478,489 In countries where such a program exists, women at 
high risk of specific fetal abnormalities and those presenting with ultrasound markers  
suggesting asuspicious of a congenital cardiac defect are referred to a specialist 
ultrasound unit for an expert review. Considering the increased incidence of placenta 
previa accreta in women with prior caesarean delivery and the high maternal 
morbidity and mortality at delivery of undiagnosed cases, similar international 
screening protocols with standard anatomical views should be developed. These 



































































clinical assessment at the first antenatal visit and at the mid-gestation routine 
ultrasound screening for fetal anomalies to improve the detection rate of placenta 
previa accreta during the second trimester of pregnancy. 
Strengths and weaknesses 
The main strengths of this review are the comprehensive search strategy, the 
identification of cases of placenta previa accreta in cohort studies on prenatal 
imaging and specific inclusion criteria (exclusion of cases with no history of 
caesarean delivery). We have also correlated ultrasound features of accreta 
placentation with obstetric outcomes highlighting the impact of prenatal diagnosis on 
management and emphasised the use of the corresponding ultrasound signs in 
screening women at high risks during the second trimester of pregnancy. 
The main limitations of this review are the publications bias of retrospective 
studies on the accuracy of ultrasound diagnosis, the heterogeneity of some of the 
studies in the diagnosis of placenta previa and variability in gestational age at 
diagnosis. Unlike, MRI, ultrasound examination is operator-dependent and thus 
single center studies often overestimate the accuracy of ultrasound because they are 
conducted by skilled operators in specialized centers and the overall numbers of 
cases of placenta accreta diagnosed prenatally in some cohorts are small.  
The ultrasound definition of placenta previa initially included all types of 
abnormally low placentation i.e. with the placenta edge inside the lower uterine 
segment. Placenta previa were then graded according to their relationship and/or the 
distance between the placental edge and the internal os of the uterine cervix.4950 The 
use of transvaginal ultrasound has allowed for a more accurate evaluation of the 



































































recommended to use the term “placenta previa” only for those placenta overlying the 
internal os and to refer to the others as “low lying”.501 Several authors in our review 
have included both low-lying and placenta previa in their cohort25,26,29,32,37, do not 
report on the use of  transvaginal ultrasound in the evaluation26-28,31,34 and/or have 
used different terminology to describe the position of the placenta inside the lower 
uterine segment. The diagnosis of placenta praevia is overestimated in pregnancies 
at less than 16 weeks of gestation and 90% of the low-lying placenta diagnosed at 
the mid-gestation scan resolved before the term.4950-534 This can explain the wide 
range (0.7-47.2%) in the incidence of placenta previa accreta reported in the cohort 
studies included in this review.  
Conclusions  
The sensitivity and specificity of ultrasound imaging in diagnosing placenta previa 
accreta in women with prior caesarean delivery, presenting with anterior low 
placenta or placenta previa are above 95% in prospective series, when performed by 
skilled operators. Women with a history of previous caesarean delivery, presenting 
with a placenta previa have become the largest group with the highest risk of 
placenta previa accreta. These specific obstetric risk factors of accreta placentation 
should be identified and integrated in the general clinical assessment at the first 
antenatal visit and at the routine mid-gestation ultrasound examination to further 
improve the detection rate of placenta previa accreta during the second trimester of 
pregnancy. Developing protocols for the screening of placenta previa accreta in 
women with prior caesarean delivery presenting with a low-lying or a placenta previa 
has become essential to improve the outcome of this increasingly more common 
major obstetric complication at national and international levels. Skills and expertise 



































































the general training of sonographers who are performing the routine mid-trimester 
detailed fetal anatomy ultrasound examination.  
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